The Company is actively seeking out-licensing opportunities in the application of our core technology to promote the development of new therapeutic products in the fields of infectious diseases, inflammation and cancer. CytoGenix is also seeking partnerships in the development of products in the areas of animal health and agriculture. Our cell-free method for the cGMP production of therapeutic-grade DNA is also available for licensing.